Parkinson's Disease Trial, Recruiting NCT07569120 Sponsor: Hospices Civils de Lyon Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07569120
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthy volunteers:

  • People aged between 20 and 80 years old
  • People who weigh between 40kg and 100kg
  • People with no history of neurological or psychiatric conditions
  • People with no history of a head injury that caused loss of consciousness for more than 30 minutes
  • Women who are able to become pregnant must be using highly effective contraception
  • People who are enrolled in a social security or equivalent scheme
  • People who are not under any form of legal protection order
  • People who have signed an informed consent form agreeing to take part

For people with Parkinson's disease:

  • People aged between 40 and 80 years old
  • People who weigh between 40kg and 100kg
  • People diagnosed with idiopathic Parkinson's disease that responds to dopamine-based treatment
  • People with no history of a head injury that caused loss of consciousness for more than 30 minutes
  • People with no additional neurological conditions alongside their Parkinson's diagnosis
  • Women who are able to become pregnant must be using highly effective contraception
  • People who are enrolled in a social security or equivalent scheme
  • People who are not under any form of legal protection order
  • People who have signed an informed consent form agreeing to take part

Who may not be able to join:

  • People who are currently taking, or have taken in the last month, certain medications that affect the brain or mood (such as antihistamines) — a specific list is held by the trial site
  • People who have a current or past diagnosis of dependence on alcohol or any addictive substance (exceptions apply for nicotine and caffeine)
  • People who are already taking part in another medical research study, or who have taken part in a study involving radiation exposure within the past year
  • Women who are pregnant, have recently given birth, or are breastfeeding
  • People who cannot have an MRI scan — this includes those with pacemakers, insulin pumps, certain metal implants or foreign objects in the body or eyes, cochlear implants, neurosensory stimulators, implantable defibrillators, certain surgical shunt valves, severe claustrophobia, or those who are unable to remain still during the scan (confirm with trial site)
  • People with a known allergy or sensitivity to the substances used in the PET scan at the study centre, including sodium chloride
  • People who, in the investigator's judgement, would be unable to understand or complete the study — for example, due to a language barrier or apparent lack of motivation
  • People who do not agree to be told if an unexpected abnormality is found during their MRI or cognitive assessments
  • People who are currently deprived of their liberty by a court or administrative decision
  • People who are currently receiving psychiatric care
  • People who are residing in a health or social care facility for reasons unrelated to research

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 472118022

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 June 2026
Est. completion
1 September 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

PET measures; IRM measure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov